In the investor note, Macquarie confirmed its outperform rating and $26.10 target price on Coles shares. At the time of ...

Despite the S&P/ASX 200 Index's slight decline, 4DMedical rises 4.5% after signing a commercial agreement with the University ...

Analysts from Macquarie have raised their 12-month target price for Megaport shares to $21.70, indicating a potential 60.7% ...

Cogstate Ltd (ASX: CGS) and GQG Partners Inc (ASX: GQG) are two of four ASX shares falling on Wednesday. Here's ...

In morning trade, the ASX healthcare stock is up 7% to $1.09. Investors have been buying the regenerative medicine company's ...

This ASX 200 stock soared 122% this year. It doesn't look like Eagers will slow down as the BYD brand keeps growing and ...

This outperforming S&P/ASX 200 Index (ASX: XJO) dividend stock looks well-placed to keep on giving in 2026. Here’s why.

The market may be edging higher today, but the same cannot be said for the ASX All Ords share in this article. In morning ...

Macquarie advocates for Lotus Resources as a strong uranium investment opportunity with a potential 65% upside, despite ...

As you can see in the chart, $3,500 invested in Tesla at the end of 2013 is now worth nearly $174,000 for a total return of 4 ...

Owning Wesfarmers Ltd (ASX: WES) shares could be good news for passive income investors. How much in dividends would $5,000 ...

Up 21% in 2025, this S&P/ASX 300 Index (ASX: XKO) tech share is well-placed to outperform again in 2026. Here’s why.